vinflunine inn trade name javlor novel fluorinated vinca alkaloid undergoing research treatment bladder cancer originally discovered team professor jeanclaude jacquesy umr cnrs poitiers developed laboratoires pierre fabre licensed bristolmyers squibb development certain countries including united states november pierre fabre medicament bristolmyers squibb announced terminating license agreement development vinflunine pierre fabre continuing discussions regulatory authorities plan file registration vinflunine bladder cancer first quarter vinflunine registered use australia advanced metastatic transitional cell carcinoma urothelial tract failure prior platinum containing regimen covered pharmaceutical benefits vinflunine commerciallyapproved agent countries salvage therapy urothelial carcinoma approval based results phase iii trial reported median os undergone phase iii clinical trial advanced transitional cell carcinoma urothelial antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikivinflunine